04:32 PM EST, 12/08/2025 (MT Newswires) -- Dyne Therapeutics ( DYN ) commenced an underwritten public offering of $300 million of common stock.
Underwriters have a 30-day option to buy up to an additional $45 million in shares, the company said Monday in a statement.
Dyne shares fell 5.4% in after-hours trading.